ARCT vs MRO
Arcturus Therapeutics Holdings Inc (ARCT) versus MRO (MRO) — a side-by-side from cached financials, not a winner call.
Arcturus Therapeutics Holdings Inc (ARCT) is a biotechnology company listed on US.
MRO (MRO) common stock.
Latest reported ARCT revenue for 2024-12-31 was $152.3M. Net income was -$80.9M. Revenue was down 8.7% from 2023-12-31 to 2024-12-31. ARCT currently screens at market cap $369.4M.
MRO does not have a complete income-statement cache yet.
ARCT currently screens at market cap $369.4M.
Not investment advice. Open the ARCT and MRO stock pages for the full models.
Not investment advice.